YC is no longer exclusively for pre-product-market-fit companies. Startups with significant traction ($1-4M ARR) and prior funding now join to leverage the network and accelerate growth, fundamentally changing the accelerator's role from incubator to launchpad.
While angel investors can afford speculative bets, venture funds operate under stricter mechanics. To invest at a high valuation like $500M, a fund must be able to underwrite a potential exit in the tens or hundreds of billions to satisfy the "return the fund" principle.
While current YC valuations ($500M+) feel like a bubble, the counterargument is that AI is a fundamentally new "intelligence unlock." Unlike past tech cycles, AI's ability to create massive, immediate value might mean today's high prices will look cheap in retrospect.
Contrary to the software-centric narrative, hardware is experiencing a significant resurgence. The latest YC batch marks a milestone with over 10% of companies being hardware-focused, signaling renewed investor interest and viability in sectors like robotics, space, and nuclear energy.
A major biotech revolution is underway as AI now enables effective 'in silico' (simulated) experiments. This shift from physical "wet labs" to cheap, infinitely scalable simulations drastically cuts time and cost for drug discovery, making audacious goals like curing cancer scientifically plausible.
The current shock over $600M YC valuations is historically consistent. Fifteen years ago, a $5M valuation at Demo Day was considered equally insane and a sign of a bubble. This historical perspective suggests that as exit sizes grow, today's high prices may become tomorrow's standard.
A new paradigm of company-building is emerging where an AI acts as the founder and CEO, focused solely on making money. In this model, the human's primary role is reduced to being the legal signatory for paperwork the AI cannot execute, as demonstrated by the YC company "Thomas".
Y Combinator operates in a high-valuation environment. Investors who are consistently shocked by these prices are advised to avoid the ecosystem altogether. Engaging only to criticize the valuation wastes founders' limited time during a critical fundraising period.